ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,062Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 117

$642K Total Retail Price of All Prescriptions

Rank: 21 out of 117

322 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 322 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

20% of this provider’s 322 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

0% of this provider’s 6,556 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 300 244 1 2
METOPROLOL TARTRATE 238 178 2 8
SODIUM CHLORIDE 222 115 3 156
OMEPRAZOLE 218 137 4 6
FUROSEMIDE 212 118 5 3
HYDROCODONE-ACETAMINOPHEN 207 98 S3 6 7
WARFARIN SODIUM 195 177 7 9
LISINOPRIL 174 151 8 4
FAMOTIDINE 172 78 9 38
NAMENDA 171 171 10 14
SIMVASTATIN 165 126 11 1
HEPARIN SODIUM 161 98 12 78
POLYETHYLENE GLYCOL 3350 145 63 13 32
ALBUTEROL SULFATE 143 78 14 79
ESCITALOPRAM OXALATE 133 115 15 42
PANTOPRAZOLE SODIUM 132 85 16 26
ZOLPIDEM TARTRATE 129 62 17 27
IPRATROPIUM BROMIDE 122 72 18 101
LANTUS 119 87 19 43
METFORMIN HCL 117 62 20 11
METOPROLOL SUCCINATE 114 88 21 12
CARBAMAZEPINE 111 12 22 209
NYSTATIN-TRIAMCINOLONE 106 31 23 99
KLOR-CON M20 104 55 24 34
HYDROCHLOROTHIAZIDE 103 91 25 13
DONEPEZIL HCL 97 97 26 10
RISPERIDONE 96 45 27 39
CLOZAPINE 95 14 28 179
BACLOFEN 85 28 29 120
EXELON 84 84 30 55
TRAZODONE HCL 84 53 30 44
MIRTAZAPINE 81 59 32 25
LIDODERM 81 73 32 46
AMLODIPINE BESYLATE 79 64 34 5
LEVETIRACETAM 78 39 35 71
DIVALPROEX SODIUM 78 26 35 65
GABAPENTIN 75 35 37 16
CARVEDILOL 74 57 38 24
CYMBALTA 74 60 38 59
ATORVASTATIN CALCIUM 67 50 40 15
NYSTATIN 66 53 41 98
CITALOPRAM HBR 65 65 42 19
TAMSULOSIN HCL 65 50 42 28
CARBIDOPA-LEVODOPA 65 39 42 45
NOVOLOG 64 60 45 90
POTASSIUM CHLORIDE 60 32 46 17
TRAMADOL HCL 60 29 46 18
ALENDRONATE SODIUM 60 50 46 21
SERTRALINE HCL 60 39 46 22
CIPROFLOXACIN HCL 58 43 50 65
ATENOLOL 57 56 51 20
METRONIDAZOLE 57 44 51 205
ADVAIR DISKUS 56 41 53 51
CELEBREX 53 53 54 85
DIOVAN 52 52 55 31
BUMETANIDE 52 42 55 96
FENTANYL 51 0 S2 57 41
QUETIAPINE FUMARATE 51 35 57 36
CLONIDINE HCL 50 38 59 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.